CITIGROUP INC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$634,000
+1052.7%
36,104
+538.3%
0.00%
Q2 2021$55,000
+400.0%
5,656
+465.6%
0.00%
Q1 2021$11,000
-26.7%
1,0000.0%0.00%
Q4 2020$15,000
+50.0%
1,000
+42.9%
0.00%
Q3 2020$10,000
+11.1%
700
-36.4%
0.00%
Q2 2020$9,000
+800.0%
1,100
+2015.4%
0.00%
Q2 2015$1,000520.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders